Copied
 
 
Formål
Formål
Selskabets formål er at være indkøbsselskab for visse datterselskaber af Novo Nordisk Fonden, Bioinnovation Institute Fonden og LIFE Fonden, herunder, men ikke begrænset til, Novo Holdings A/S, samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
Sidst opdateret den 23.06.2022 og angivet som gældende fra 23.06.2022 (881 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 23.06.2022 og angivet som gældende fra 01.07.2022 (873 dage).
HistorikStartStop
NORMAL01.07.2022
UDEN RETSVIRKNING23.06.202230.06.2022
Branche
Branche
Ikke-specialiseret engroshandel (469000).
Sidst opdateret den 23.06.2022 og angivet som gældende fra 23.06.2022 (881 dage).
Ingen historik.
Revision
Revisionfravalgt
false.
Sidst opdateret den 23.06.2022 og angivet som gældende fra 23.06.2022 (881 dage).
Ingen historik.
Revisor
Revisor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 23.06.2022 og angivet som gældende fra 01.07.2022 (873 dage).
Ingen historik.
Form
Virksomhedsform
60.
Sidst opdateret den 23.06.2022 og angivet som gældende fra 23.06.2022 (881 dage).
Ingen historik.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
Ingen nuværende registrering.
Ingen historik.
Navne
Ingen historik.
Tegningsregel
Tegningsregel
Selskabet tegnes af formanden for bestyrelsen i forening med en direktør, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Sidst opdateret den 23.06.2022 og angivet som gældende fra 23.06.2022 (881 dage).
Fortolkning (3 tegningsmuligheder)
formanden + 1 direktør
2 bestyrelsesmedlemmer +
bestyrelsen
Ingen historik.
Ansatte
20.11.2024
Ingen historik.
Kapital
20.11.2024
Fra årsrapport
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):Basis for OpinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinionIn our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2023, and of the results of the Company’s operations for the financial period 1 July 2022 - 31 December 2023 in accordance with the Danish Financial Statements Act. We have audited the Financial Statements of Indkøbsselskabet Novo Holdings A/S for the financial period 1 July 2022 - 31 December 2023, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies (“financial statements”).
Udtalelse om ledelsesberetningen (revision):Statement on Management's ReviewManagement is responsible for Management’s Review. Our opinion on the financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, in our view, Management’s Review is in accordance with the Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement in Management’s Review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
20.11.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
20.11.2024
Ingen nuværende registrering.
Ingen historik.